| PUBCHEM ID |
72941665
|
| UNII |
18N080585M
|
| Preferred Term |
.DELTA.9(11)-TESTOSTERONE ENANTHATE
|
| CAS |
119698-27-0
|
| INCHIKEY |
YLZQRXWCRVQXTO-QAXGJQJKSA-N
|
| Download |
mol2, pdbqt
|
| mol2 |
|
| Smiles |
CCCCCCC(O[C@@H](CC1)[C@]2(C)[C@@H]1[C@H](CCC([C@]1(C)CC3)=CC3=O)C1=CC2)=O
|
| Total Surface Area |
314,64
|
| Relative PSA |
0,11467
|
| TPSA |
43,37
|
| cLogS |
-5,557
|
| MW |
398,585
|
| cLogP |
6,1483
|
| H-Acceptors |
3
|
| H-Donors |
0
|
| Ro5 violations |
1
|
| Druglikeness |
-20,392
|
| DrugScore |
0,187422611726611
|
| Mutagenic |
none
|
| Tumorigenic |
none
|
| Reproductive Effective |
none
|
| Irritant |
none
|
| Blood-Brain Barrier |
BBB+
|
| Human Intestinal Absorption |
HIA+
|
| Caco-2 Permeability I |
Caco2+
|
| Caco-2 Permeability II |
1,0657
|
| P-glycoprotein Substrate |
Substrate
|
| P-glycoprotein Inhibitor I |
Inhibitor
|
| P-glycoprotein Inhibitor II |
Inhibitor
|
| Renal Organic Cation Transporter |
Non-inhibitor
|
| Subcellular localization |
Mitochondria
|
| CYP450 2C9 Substrate |
Non-substrate
|
| CYP450 2D6 Substrate |
Non-substrate
|
| CYP450 3A4 Substrate |
Substrate
|
| CYP450 1A2 Inhibitor |
Non-inhibitor
|
| CYP450 2C9 Inhibitor |
Non-inhibitor
|
| CYP450 2D6 Inhibitor |
Non-inhibitor
|
| CYP450 2C19 Inhibitor |
Inhibitor
|
| CYP450 3A4 Inhibitor |
Non-inhibitor
|
| CYP Inhibitory Promiscuity |
Low CYP Inhibitory Promiscuity
|
| Human Ether-a-go-go-Related Gene Inhibition I |
Weak inhibitor
|
| Human Ether-a-go-go-Related Gene Inhibition II |
Non-inhibitor
|
| AMES Toxicity |
Non AMES toxic
|
| Carcinogens |
Non-carcinogens
|
| Fish Toxicity I |
High FHMT
|
| Fish Toxicity II |
-0,5053
|
| Tetrahymena Pyriformis Toxicity I |
High TPT
|
| Tetrahymena Pyriformis Toxicity II |
1,6514
|
| Tetrahymena Pyriformis Toxicity |
High HBT
|
| Biodegradation |
Not ready biodegradable
|
| Acute Oral Toxicity |
III
|
| Rat Acute Toxicity |
2,0463
|
| Carcinogenicity (Three-class) |
Non-required
|
